Beijing DCTY Biotech

Dingchi Biotech is a Chinese biotechnology company specializing in large-scale cell culture technology and the development of high-end vaccines and viral vectors. The company has developed the proprietary ST-1 suspension cell line, which enables high-density, serum-free cultivation for various viral products. Dingchi operates as both a product developer, focusing on veterinary and human vaccines, and a CDMO provider for the biopharmaceutical industry. Their integrated platform covers the entire value chain from cell line development to commercial-scale GMP manufacturing. The company's veterinary pipeline includes advanced vaccines for foot-and-mouth disease and classical swine fever, while its human health division focuses on viral vector production and rabies prevention.